Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICUCW) EPS (Weighted Average and Diluted) (2023 - 2025)

SeaStar Medical Holding's EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at -$0.18 for Q2 2025.

  • For Q2 2025, EPS (Weighted Average and Diluted) rose 82.52% year-over-year to -$0.18; the TTM value through Jun 2025 reached -$2.25, up 88.08%, while the annual FY2024 figure was -$6.63, 78.09% up from the prior year.
  • EPS (Weighted Average and Diluted) reached -$0.18 in Q2 2025 per ICUCW's latest filing, up from -$0.44 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$0.18 in Q2 2025 to a low of -$9.02 in Q3 2023.
  • Average EPS (Weighted Average and Diluted) over 3 years is -$2.58, with a median of -$1.06 recorded in 2024.
  • Peak YoY movement for EPS (Weighted Average and Diluted): crashed 775.93% in 2024, then surged 90.7% in 2025.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$4.1 in 2023, then soared by 87.07% to -$0.53 in 2024, then surged by 66.04% to -$0.18 in 2025.
  • Per Business Quant, the three most recent readings for ICUCW's EPS (Weighted Average and Diluted) are -$0.18 (Q2 2025), -$0.44 (Q1 2025), and -$0.53 (Q4 2024).